Aaron Davenport, Managing Director at SK Capital, commented, “We are thrilled to welcome Pascal, who we believe is uniquely positioned to lead Seqens in its next chapter, bringing a track record of ...

pharmaphorum looks at its evolution over the centuries. The roots of the pharmaceutical industry lie back with the apothecaries and pharmacies that offered traditional remedies as far back as the ...

In today’s fast-paced world, threats can evolve quickly and without warning. As the pharmaceutical industry has operations and supply chains spanning the globe, companies are vulnerable to ...

Matcon specialises in providing complete materials handling solutions for OSD and API pharmaceutical manufacturers. We design optimised systems for improved productivity & quality.

India currently levies an around 10% import duty on drugs from the US, while the US doesn't charge any import duty on drugs from India. Representatives of pharma companies and industry lobby groups ...

The Indian pharmaceutical industry has raised alarms over the potential imposition of US tariffs on pharmaceutical exports, warning that such a move could lead to increased drug costs and potential ...

Indian pharmaceutical industry leaders indicate that proposed US tariffs on pharmaceutical exports may lead to increased drug costs and potential shortages in the US. They argue that the tariffs might ...

IPC Indice de Precios Y Cotizaciones 51,877.12-163.89-0.31% ...

The Indian pharmaceutical industry is unlikely to face major setbacks from potential US tariffs, as its exports primarily consist of low-cost, inelastic generic medicines that remain in high demand.

The pharmaceutical industry is on the cusp of transformative change, with advancements in personalized medicine, biotechnology, AI, digital health, and regulatory frameworks driving innovation and ...

Getting a front-end manufacturing foothold in the U.S. appears to be the way out for India’s generic drugmakers in the event of U.S. levying tariff on pharmaceuticals, a top executive of a well ...